(Q34746443)
Statements
1 reference
Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group (English)
1 reference
M Tanaka
1 reference
T Matsumoto
1 reference
M Sakumoto
1 reference
K Takahashi
1 reference
T Saika
1 reference
I Kabayashi
1 reference
J Kumazawa
1 reference
1 reference
1 reference